The Feasibility and Safety of Instruments in Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer

NCT02943694 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Postoperative Complications

Interventions

DEVICE: TaTME with CS-Compact (GelPoint pathway)

Sponsor

Ruijin Hospital

Collaborators

[object Object]